Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Operations and Comprehensive Loss

v3.3.0.814
Condensed Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Sep. 30, 2015
Sep. 30, 2014
Operating expenses:        
Research and development $ 4,528 $ 3,848 $ 12,975 $ 10,546
General and administrative 2,201 1,687 7,075 5,853
Total operating expenses 6,729 5,535 20,050 16,399
Loss from operations (6,729) (5,535) (20,050) (16,399)
Other income (expense):        
Interest income 46 19 99 48
Interest expense (265) (191) (584) (565)
Other income (expense), net 1,083 (254) 10,985 (2,279)
Net loss (5,865) (5,961) (9,550) (19,195)
Net loss (5,865) (5,961) (9,550) (19,195)
Other comprehensive (loss) income:        
Unrealized gain (loss) on marketable securities 5 (15) 6 (17)
Other comprehensive income (loss) 5 (15) 6 (17)
Comprehensive loss $ (5,860) $ (5,976) $ (9,544) $ (19,212)
Basic net loss per common share $ (0.27) $ (0.44) $ (0.55) $ (1.72)
Diluted net loss per common share $ (0.27) $ (0.44) $ (0.58) $ (1.72)
Weighted average common shares outstanding used to calculate basic net loss per common share 21,674,742 13,468,081 17,368,309 11,148,695
Weighted average common shares outstanding used to calculate diluted net loss per common share 21,674,742 13,468,081 17,384,000 11,148,695